Recent articles
Can This High-Yield Utility Elbow Its Way to Renewable Energy Leadership?
American Electric Power is one of the largest utility holding companies in the United States, but it's lagging behind its peers in renewable energy.
Here's Why Assembly Biosciences Stock Soared Today
The company reported promising updates for two important pipeline programs.
Amyris Files First-Half 2019 Reports: What Investors Need to Know
The filings provide a glimpse of the company's struggles. Can cannabinoids pull the business out of the doldrums?
3 Things Repligen Investors Need to Watch
The year may be drawing to a close, but this biomanufacturing stock -- and any investor interested in it -- has plenty to look forward to.
Why Amarin Investors Have Their Eyes on Nov. 14
An important regulatory milestone has been pushed back to late December, although investors will be awaiting voting results from a meeting in mid-November.
Here's Why Steel Stocks Erupted for Big Gains on Friday
The United States and China reached a partial deal in the ongoing trade war.
Here's Why Aerie Pharmaceuticals Rose as Much as 21.8% Today
A new slide deck shows reasons for optimism.
Here's Why Nektar Therapeutics Stock Fell as Much as 11.6% Today
An analyst downgrade is only adding to the company's woes.
Here's Why Puma Biotechnology Tumbled Today
An analyst downgrade and a departing executive make for a bad day.
Here's Why Livongo Health Gained as Much as 16.9% Today
A big contract could keep fueling growth.
Here's Why Myriad Genetics Jumped 21.7% in September
The genetic-testing stock can't seem to escape the trap of volatility.
Here's Why PTC Therapeutics Fell 24.1% in September
The company more than doubled its cash balance from the end of June with two fundraising transactions.
Here's Why TherapeuticsMD Jumped 25.6% in September
The path ahead is looking a bit brighter for this pharmaceutical company.
Here's Why Repligen Stock Tumbled 17.4% in September
Sometimes stocks go up, sometimes they go down.
Here's Why Sarepta Therapeutics Fell 16.5% in September
The stock continued a slide that began in August, but shares have started heading higher again in October on the heels of promising clinical data.
Here's Why Tandem Diabetes Care Fell 18.6% in September
The growth stock cooled off a bit last month but has still managed to scorch the market with a 51% year-to-date gain.
Here's Why U.S. Concrete Rose 36.4% in September
The threat of a recession hasn't sapped demand for construction projects, which allowed shares to claw their way to a year-to-date high.
Bloom Energy Takes to the Seas With Samsung Heavy Industries
Cargo ships could lean on natural-gas-powered fuel cells to significantly reduce carbon emissions. Can the opportunity help Bloom Energy to overcome its struggles?
Here's Why Genetic Testing Stocks Tumbled in September
Most stocks in the industry cooled off from all-time highs. Will they keep sliding?
These 2 Neuroscience Stocks Have Tanked as Much as 33% Since September 1. Are They Buys?
Two healthcare stocks, two plunging stock prices, and two unique scenarios heading into the end of 2019.